CDXS Codexis, Inc.

CDXS Codexis, Inc.

Healthcare · Biotechnology

Market read

POC $1.59 · VWAP $1.79 · -30.6% vs 12m avg buyer

collapse vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CEO + 1 other sold $17.2K, Oct 14

Coverage

1 watchlist

Watchlists @biotech-capital-cycle

CDXS Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist CDXS belongs to, members best 30-day change first — CDXS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
NAUT+111.9% -4.6%1d -8.4%7d QSI+53.4% -14.5%1d -26.8%7d DNA+45.5% -12.7%1d -21.0%7d PACB+29.1% -11.7%1d -25.8%7d MTD+17.7% -1.0%1d +4.7%7d CERT+15.3% -3.0%1d +2.6%7d ILMN+14.7% -2.0%1d -5.6%7d FTRE+12.6% -1.1%1d +7.9%7d A+12.5% -1.5%1d +1.4%7d DHR+9.9% -1.1%1d +4.2%7d CRL+9.8% -2.0%1d -0.5%7d RXRX+8.8% -16.6%1d -20.4%7d SEER+6.8% -0.5%1d -7.3%7d TMO+6.4% -0.9%1d +4.9%7d AVTR+5.2% +2.0%1d +4.8%7d RVTY+4.7% -1.3%1d -1.0%7d WAT+4.4% -1.6%1d +0.7%7d ABSI+2.6% -7.1%1d -18.8%7d RGEN+1.4% -4.8%1d +0.9%7d ABCL+1.1% -6.9%1d -6.0%7d MEDP+0.3% -1.6%1d +1.1%7d IQV-0.7% -1.5%1d +2.7%7d QTRX-1.4% -6.5%1d -12.5%7d ICLR-2.2% -2.8%1d +3.7%7d TXG-3.9% -3.5%1d -13.4%7d AGIO-5.0% -3.1%1d -1.5%7d SDGR-5.6% -11.3%1d -17.2%7d XBI-6.4% -3.6%1d -6.2%7d TWST-7.2% -8.1%1d -16.9%7d CDXS-7.5% -8.8%1d -12.1%7d TEM-7.5% -9.0%1d -8.8%7d BRKR-9.7% -3.1%1d -6.9%7d LAB-11.3% -4.5%1d -8.8%7d ALMR-14.0% -7.8%1d 0.0%7d VKTX-14.7% -8.0%1d -11.7%7d GENB-22.9% -7.4%1d -15.7%7d

Next earnings CDXS reports in 19 days Nov 5

Last report Aug 11

Codexis furnished its earnings release to the SEC on August 11, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 the same day. No figures from these filings are recorded here.

full note →

Against street estimates

How CDXS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 11 · projection Oct 16

Result
Aug 11 -0.12-0.13-8.3%Miss
May 7 -0.10-0.10+4.8%Beat
Mar 11 -0.040.14+508.6%Beat
Nov 6 '25 -0.13-0.22-73.7%Miss
Aug 13 '25 -0.15-0.16-6.7%Miss
May 14 '25 -0.21-0.25-20.5%Miss
Feb 27 '25 -0.02-0.13-499.9%Miss
Oct 31 '24 -0.21-0.29-35.5%Miss

CDXS research tape

6 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Washout-Turn Scan — 2026-08-31 scan Washout-Turn Scan — 2026-08-27 scan Washout-Turn Scan — 2026-08-26 scan Washout-Turn Scan — 2026-08-25 scan Washout-Turn Scan — 2026-08-24
Types
Aug 31 Scan Washout Turn Scan
AAAAUCACNAIALNYARMPBAHBBAI +4 more
Aug 27 Scan Washout Turn Scan
AAAAUCACNADA-USDAGIAIALBALT +4 more
Aug 26 Scan Washout Turn Scan
AAUCADA-USDADBEAGIALBALTARMPAVAX-USD +4 more
Aug 25 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIALBALT +4 more
Aug 24 Scan Washout Turn Scan
AAUCACNADA-USDADBEAGIAIALBALT +4 more
Aug 11 Catalyst CDXS earnings
CDXS